Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Change in Intangibles (2010 - 2015)

Vycor Medical (VYCO) reported Change in Intangibles of $66276.0 for Q1 2015, up 1136.26% year-over-year from $5361.0 in Q1 2014, and up 373.67% on a QoQ basis from $13992.0 in Q3 2014.

Vycor Medical (VYCO) has 6 years of Change in Intangibles data on file, last reported at $66276.0 in Q1 2015.

  • Quarterly Change in Intangibles rose 1136.26% year-over-year to $66276.0 in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $66276.0 (changed N/A YoY) and the FY2015 annual result came in at $66276.0, up 88.46% from the prior year.
  • Change in Intangibles improved to $66276.0 in Q1 2015 per VYCO's latest filing, from $13992.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $66276.0 in Q1 2015 and bottomed at -$22958.0 in Q4 2012.
  • The 5-year median for Change in Intangibles is $13992.0 (2014), against an average of $19797.2.
  • The widest annual swing landed in 2012, when Change in Intangibles plunged 147.14%; it then jumped 1160.73% in 2013.
  • Tracing VYCO's Change in Intangibles over 5 years: stood at $53971.0 in 2011, then tumbled by 142.54% to -$22958.0 in 2012, then surged by 91.31% to -$1995.0 in 2013, then soared by 801.35% to $13992.0 in 2014, then soared by 373.67% to $66276.0 in 2015.
  • Per Business Quant, the three latest VYCO Change in Intangibles figures stand at $66276.0 (Q1 2015), $13992.0 (Q3 2014), and $838.0 (Q2 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -31.61 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Vycor Medical - - 375,153.00 -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2015 66,276.00
Mar 31, 2015 66,276.00
Sep 30, 2014 13,992.00
Sep 30, 2014 13,992.00
Jun 30, 2014 838.00
Jun 30, 2014 838.00
Mar 31, 2014 5,361.00
Mar 31, 2014 5,361.00
Dec 31, 2013 -1,995.00
Dec 31, 2013 -1,995.00
Sep 30, 2013 10,290.00
Sep 30, 2013 10,290.00
Jun 30, 2013 19,316.00
Jun 30, 2013 19,316.00
Mar 31, 2013 39,141.00
Mar 31, 2013 39,141.00
Dec 31, 2012 -22,958.00
Dec 31, 2012 -22,958.00
Sep 30, 2012 40,214.00
Sep 30, 2012 40,214.00
Jun 30, 2012 19,767.00
Jun 30, 2012 19,767.00
Mar 31, 2012 -3,690.00
Mar 31, 2012 -3,690.00
Dec 31, 2011 53,971.00
Dec 31, 2011 53,971.00
Jun 30, 2011 48,607.00
Jun 30, 2011 48,607.00
Mar 31, 2011 7,828.00
Mar 31, 2011 7,828.00
Dec 31, 2010 4,792.00
Dec 31, 2010 4,792.00